Pfizer agrees to $2M settlement deal over gender discrimination allegationsnews2023-10-18T17:23:21+00:00October 18th, 2023|Endpoints News|
NIH director nominee Bertagnolli skirts drug pricing questions at confirmation hearingnews2023-10-18T16:59:44+00:00October 18th, 2023|Endpoints News|
FDA clears Intellia’s IND for PhIII trial of ATTR amyloidosis CRISPR treatmentnews2023-10-18T15:28:46+00:00October 18th, 2023|Endpoints News|
Ligand pays $30M upfront in royalty deal; Actym extends its Series A; Gero raises $6Mnews2023-10-18T15:15:43+00:00October 18th, 2023|Endpoints News|
Syncona eyes buyout of gene therapy biotech Freeline after early data in two Gaucher patientsnews2023-10-18T14:45:43+00:00October 18th, 2023|Endpoints News|
Regeneron, AstraZeneca and others partner with HBCU to create African ancestry genomics databasenews2023-10-18T14:33:54+00:00October 18th, 2023|Endpoints News|
Women’s chronic care startup Allara raises $10M to expand nationwidenews2023-10-18T13:00:03+00:00October 18th, 2023|Endpoints News|
BrainStorm withdraws ALS drug application after negative adcomm votenews2023-10-18T12:41:25+00:00October 18th, 2023|Endpoints News|
Medicaid startup Waymark raises $42M in a round led by Lux Capitalnews2023-10-18T12:00:27+00:00October 18th, 2023|Endpoints News|
Orasis gains FDA approval for presbyopia eye drops, following in AbbVie’s footstepsnews2023-10-18T11:17:13+00:00October 18th, 2023|Endpoints News|
